Physician profile
Janet M Mint
NPI 1902894777
$8,371.18
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,442 · 2020: $1,735 · 2021: $332 · 2022: $1,605 · 2023: $940 · 2024: $58.33 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Entertainment: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.59 |
| Entertainment | $101.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $5,585.06 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $445.81 | 2019-2025 | Total30, Precision7 |
| Coopervision INC. | $426.23 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $338.12 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $309.22 | 2019-2023 | Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $245.26 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $214.30 | 2022-2025 | Infuse |
| Optos, INC. | $138.60 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $135.62 | 2021 | |
| Lkc Technologies, INC. | $125.98 | 2023 | |
| Allergan, INC. | $116.69 | 2021 | |
| Lombart Brothers, INC. | $105.78 | 2025 | Opd-III |
| Optovue, INC. | $78.78 | 2019 | |
| Maculogix, INC. | $49.20 | 2019 | |
| Heru, INC. | $33.19 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $23.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Mint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.